| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 14th September 2020 | Glen Tullman | 23 | Open or private sale | $124.46 | $2,862.58 |
| 14th September 2020 | Lee Shapiro | 23 | Open or private sale | $124.46 | $2,862.58 |
| 11th September 2020 | Glen Tullman | 36,576 | Other acquisition or disposition | $0.00 | |
| 11th September 2020 | Lee Shapiro | 395,025 | Other acquisition or disposition | $0.00 | |
| 11th September 2020 | Glen Tullman | 312,511 | Other acquisition or disposition | $0.00 | |
| 11th September 2020 | Glen Tullman | 395,025 | Other acquisition or disposition | $0.00 | |
| 11th September 2020 | Glen Tullman | 58,773 | Other acquisition or disposition | $0.00 | |
| 11th September 2020 | Lee Shapiro | 58,773 | Other acquisition or disposition | $0.00 | |
| 11th September 2020 | Lee Shapiro | 36,576 | Other acquisition or disposition | $0.00 | |
| 11th September 2020 | Glen Tullman | 65,081 | Other acquisition or disposition | $0.00 |
Livongo Health
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 6/10.
Livongo Health, Inc. develops and operates a consumer digital health platform. It focuses on diabetes, hypertension, weight management, diabetes prevention, and behavioral health. The company was founded by Kimon Angelides and Glen E. Tullman on October 16, 2008.
Ticker: LVGO
Sector: Technology Services
Industry: Packaged Software
SEC Central Index Key (CIK): 1639225
Employees: 615
Exchange: NASDAQ
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
Increase Decrease In Due To Related Parties of $0 for the period Jan 2020 to Jun 2020 in the context of all up
Increase Decrease In Due To Related Parties of $2 M for the period Jan 2019 to Jun 2019 in the context of all up
Fundamentals
Cash at Carrying Value: $686 M (0%)
Inventory, Net: $18 M (-39%)
Other Assets, Current: $0 (-100%)
Assets, Current: $951 M (95%)
Property, Plant and Equipment, Net: $16 M (0%)
Other Assets, Noncurrent: $569 Th (0%)
Assets: $1 B (87%)
Accounts Payable, Current: $6 M (-23%)
Accrued Liabilities, Current: $36 M (0%)
Liabilities, Current: $48 M (14%)
Other Liabilities, Noncurrent: $397 Th (-86%)
Liabilities: $471 M (785%)
Common Stock, Value, Issued: $100 Th (5%)
Retained Earnings (Accumulated Deficit): $171 M (0%)
Stockholders' Equity (Parent): $578 M (0%)
Liabilities and Equity: $1 B (87%)
Revenue: $92 M (-42%)
Cost of Revenue: $21 M (-45%)
Gross Margin: $70 M (-41%)
Research and Development: $16 M (-46%)
Sales and Marketing: $33 M (-45%)
General and Administrative Expenses: $22 M (-41%)
Operating Income/Loss: $262 Th (-96%)
Provision for income taxes: $72 Th (-22%)
News
Alphabet settles shareholder suit over sexual harassment claims
25th September 2020
Netherlands Sets New Covid-19 Record For 5 Days In A Row
25th September 2020
Alphabet to set up council to oversee diversity, equity efforts
25th September 2020
China aims to make 1 billion COVID-19 vaccine doses a year
25th September 2020
Netherlands Sets New Covid-19 Record For 5 Days In A Row
25th September 2020